Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeiGene
Biotech
BeiGene inks $150M deal to follow cancer trail blazed by Amgen
BeiGene has struck a $150 million deal to license an asset from CSPC, clearing it to explore a combination that has attracted the interest of Amgen.
Nick Paul Taylor
Dec 13, 2024 9:11am
AbbVie sues BeiGene over blood cancer drug trade secrets
Sep 11, 2024 10:17am
BeiGene offers up $1.3B in biobucks for preclinical cancer drug
Nov 21, 2023 7:13am
Novartis retreats from TIGIT, handing $300M drug back to BeiGene
Jul 11, 2023 9:20am
BeiGene bags option on DualityBio ADC in backloaded $1.3B deal
Jul 10, 2023 9:00am
Ex-J&J research chief lands at FogPharma—Chutes & Ladders
Mar 31, 2023 9:30am
